BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brungs D, Minaei E, Piper AK, Perry J, Splitt A, Carolan M, Ryan S, Wu XJ, Corde S, Tehei M, Aghmesheh M, Vine KL, Becker TM, Ranson M. Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancer. Sci Rep 2020;10:539. [PMID: 31953491 DOI: 10.1038/s41598-019-57164-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Rousset X, Maillet D, Grolleau E, Barthelemy D, Calattini S, Brevet M, Balandier J, Raffin M, Geiguer F, Garcia J, Decaussin-petrucci M, Peron J, Benzerdjeb N, Couraud S, Viallet J, Payen L. Embryonated Chicken Tumor Xenografts Derived from Circulating Tumor Cells as a Relevant Model to Study Metastatic Dissemination: A Proof of Concept. Cancers 2022;14:4085. [DOI: 10.3390/cancers14174085] [Reference Citation Analysis]
2 De Renzi G, De Marco G, De Meo M, Del Rosso E, Gazzaniga P, Nicolazzo C. In vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity. Cancer Drug Resist 2022;5:245-60. [PMID: 35582538 DOI: 10.20517/cdr.2021.121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shimada Y, Sudo T, Akamatsu S, Sunada T, Myomoto A, Okano K, Shimizu K. Cell Lines of Circulating Tumor Cells: What Is Known and What Needs to Be Resolved. JPM 2022;12:666. [DOI: 10.3390/jpm12050666] [Reference Citation Analysis]
4 Espejo-Cruz ML, González-Rubio S, Zamora-Olaya J, Amado-Torres V, Alejandre R, Sánchez-Frías M, Ciria R, De la Mata M, Rodríguez-Perálvarez M, Ferrín G. Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal. Int J Mol Sci 2021;22:13073. [PMID: 34884878 DOI: 10.3390/ijms222313073] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Maeda Y, Yoshino T, Kogiso A, Negishi R, Takabayashi T, Tago H, Lim TK, Harada M, Matsunaga T, Tanaka T. Lensless imaging-based discrimination between tumour cells and blood cells towards circulating tumour cell cultivation. Analyst 2021;146:7327-35. [PMID: 34766603 DOI: 10.1039/d1an01414e] [Reference Citation Analysis]
6 Kejík Z, Kaplánek R, Dytrych P, Masařík M, Veselá K, Abramenko N, Hoskovec D, Vašáková M, Králová J, Martásek P, Jakubek M. Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design. Pharmaceutics 2021;13:1879. [PMID: 34834295 DOI: 10.3390/pharmaceutics13111879] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
7 Carmona-Ule N, González-Conde M, Abuín C, Cueva JF, Palacios P, López-López R, Costa C, Dávila-Ibáñez AB. Short-Term Ex Vivo Culture of CTCs from Advance Breast Cancer Patients: Clinical Implications. Cancers (Basel) 2021;13:2668. [PMID: 34071445 DOI: 10.3390/cancers13112668] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
8 Smit DJ, Pantel K, Jücker M. Circulating tumor cells as a promising target for individualized drug susceptibility tests in cancer therapy. Biochem Pharmacol 2021;188:114589. [PMID: 33932470 DOI: 10.1016/j.bcp.2021.114589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 Perry J, Ashford B, Thind AS, Gauthier ME, Minaei E, Major G, Iyer NG, Gupta R, Clark J, Ranson M. Comprehensive Mutational and Phenotypic Characterization of New Metastatic Cutaneous Squamous Cell Carcinoma Cell Lines Reveal Novel Drug Susceptibilities. Int J Mol Sci 2020;21:E9536. [PMID: 33333825 DOI: 10.3390/ijms21249536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
10 Dobie C, Skropeta D. Insights into the role of sialylation in cancer progression and metastasis. Br J Cancer 2021;124:76-90. [PMID: 33144696 DOI: 10.1038/s41416-020-01126-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
11 Kilgour E, Rothwell DG, Brady G, Dive C. Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance. Cancer Cell 2020;37:485-95. [PMID: 32289272 DOI: 10.1016/j.ccell.2020.03.012] [Cited by in Crossref: 54] [Cited by in F6Publishing: 115] [Article Influence: 27.0] [Reference Citation Analysis]
12 Werno C, Honarnejad K, Polzer B. Predicting therapy response by analysis of metastasis founder cells: emerging perspectives for personalized tumor therapy. Expert Review of Precision Medicine and Drug Development 2020;5:413-20. [DOI: 10.1080/23808993.2020.1831910] [Reference Citation Analysis]